tradmap

KMTS Earnings KESTRA MEDICAL TECHNOLOGIES, LTD.

Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated

Annual results

Diluted EPS (annual)
-$5 -$3 $0 2024 2025 2026
EPS
Revenue (annual)
$0 $48M $95M 2024 2025 2026
Revenue
Net income (annual)
-$132M -$66M $0 2024 2025 2026
Net income

Quarterly results

Diluted EPS (quarterly)
-$4 -$2 $0 Q3 '24 Q4 '24 Q1 '25 Q3 '25 Q4 '25 Q1 '26 Q3 '26
EPS
Revenue (quarterly)
$0 $14M $29M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26
Revenue
Net income (quarterly)
-$52M -$26M $0 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26
Net income

Reported EPS history

1–10 of 10
Q1 20262026-07-31-0.752026-09-1410-Q
FY 20262026-04-30-2.432026-07-1410-K
Q3 20262026-01-31-1.762026-03-1710-Q
Q2 20252025-10-31-1.142025-12-1110-Q
Q1 20262025-07-31-0.502026-09-1410-Q
FY 20262025-04-30-5.132026-07-1410-K
Q3 20262025-01-31-3.562026-03-1710-Q
Q2 20252024-10-31-2.312025-12-1110-Q
Q1 20252024-07-31-1.122025-09-1210-Q
FY 20252024-04-30-5.072025-07-1710-K

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.